Fortitude Family Office’s CorMedix CRMD Stock Holding History

Fortitude Family Office’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$479	Buy	+61	New	+$482	﹤0.01%	1990

Other funds holding CRMD

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

American Financial Advisors Marietta, Georgia $831M AUM 21.38% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

West Michigan Advisors Holland, Michigan $455M AUM 31.82% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fortitude Family Office's CRMD Position: Q2 2026 in Review

Fortitude Family Office opened a new position in CorMedix (CRMD) in Q2 2026: 61 shares worth $479. The stake represents ﹤0.01% of the portfolio and ranks #1990 among its holdings.

22 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Fortitude Family Office held 61 shares of CorMedix worth $479 as of Q2 2026.
CorMedix was a new Fortitude Family Office position in Q2 2026.
CorMedix made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1990 holding.
22 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.